Insider Transactions in Q1 2022 at Acelrx Pharmaceuticals Inc (ACRX)
Insider Transaction List (Q1 2022)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 03
2022
|
Vincent J. Angotti CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
23,051
-2.32%
|
$0
$0.41 P/Share
|
Mar 03
2022
|
Raffi Asadorian Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,923
-2.13%
|
$0
$0.41 P/Share
|
Mar 03
2022
|
Badri N Dasu Chief Engineering Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,612
-1.83%
|
$0
$0.41 P/Share
|
Mar 03
2022
|
Pamela P Palmer Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,923
-1.01%
|
$0
$0.41 P/Share
|
Feb 11
2022
|
Vincent J. Angotti CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
23,058
-2.29%
|
$0
$0.4 P/Share
|
Feb 11
2022
|
Vincent J. Angotti CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
390,000
+27.92%
|
-
|
Feb 11
2022
|
Raffi Asadorian Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,927
-2.11%
|
$0
$0.4 P/Share
|
Feb 11
2022
|
Raffi Asadorian Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
117,500
+23.81%
|
-
|
Feb 11
2022
|
Badri N Dasu Chief Engineering Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,615
-1.86%
|
$0
$0.4 P/Share
|
Feb 11
2022
|
Badri N Dasu Chief Engineering Officer |
BUY
Grant, award, or other acquisition
|
Direct |
97,500
+24.42%
|
-
|
Feb 11
2022
|
Pamela P Palmer Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,927
-1.01%
|
$0
$0.4 P/Share
|
Feb 11
2022
|
Pamela P Palmer Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
122,500
+13.5%
|
-
|
Feb 06
2022
|
Vincent J. Angotti CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
27,318
-4.24%
|
$0
$0.43 P/Share
|
Feb 06
2022
|
Raffi Asadorian Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,391
-3.51%
|
$0
$0.43 P/Share
|
Feb 06
2022
|
Badri N Dasu Chief Engineering Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,830
-3.23%
|
$0
$0.43 P/Share
|
Feb 06
2022
|
Pamela P Palmer Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,391
-1.4%
|
$0
$0.43 P/Share
|